WASHINGTON (PRWEB) August 12, 2020
Floreo Inc., a leading science-backed virtual reality platform for teaching social, communication, and life skills for people with autism spectrum disorder (ASD), today announced it has entered into a collaborative research and development agreement (CRADA) with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). Under the CRADA, Floreo and NHGRI will jointly develop and pilot immersive virtual reality (VR) modules focused on improving cognitive deficits frequently implicated in attention deficit hyperactivity disorder (ADHD).
Floreo’s patented virtual reality application currently provides immersive and engaging therapy to help individuals with ASD or other social and communication skill deficits build real world skills. Floreo is currently being used by schools, therapy practices and parents. Floreo’s ongoing research includes a National Institute for Mental Health (NIMH) Small Business Technology Transfer research grant to study the effect of VR law enforcement encounter training on police interaction skills in adolescents and adults with autism, in collaboration with Children’s Hospital of Philadelphia’s Center for Autism Research.
Phillip Shaw, Ph.D., from NHGRI will be the lead investigator along with Floreo’s Medical Director, Sinan Turnicioglu, MD. Dr. Shaw focuses on genomic and neural features underlying ADHD in children and adults.
“The new partnership with NHGRI is an exciting opportunity for Floreo to expand our virtual reality-driven platform to address specific skill development for ADHD,” says Vijay Ravindran, Chief Executive Officer of Floreo. “ADHD is a common co-occurring condition with ASD and is a natural extension for our cognitive training modules.”
“Many children who have ADHD face cognitive challenges. The goal of this collaboration will be to develop an effective, safe and engaging virtual reality intervention that can help children overcome some of these challenges,” says Dr. Shaw.
About Floreo, Inc.
Floreo, Inc. (Floreo) is the leading science-backed virtual reality platform for teaching social, communication, and life skills for people with ASD. The proprietary technology of Floreo that will be applied to this research partnership utilizes a patented process that uses software in conjunction with a virtual reality headset to provide supervised, fun, interactive, real-world scenarios that build skills in critical areas of cognitive intervention. The company is based in Washington DC. Find out more at floreotech.com.